{"id":"W4412552202","doi":"10.1007/s12325-025-03305-5","title":"Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration","year":2025,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Rheumatology; Axial spondyloarthritis; Quality of life (healthcare); Duration (music); Internal medicine; Signs and symptoms; Physical therapy; Arthritis; Psoriatic arthritis; Sacroiliitis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001100564,0.0001386763,0.0004997296,0.0001629422,0.00002818353,0.000003768499,0.00004116944,0.00005158448,0.000009932761],"category_scores_gemma":[0.00008492219,0.000110201,0.00003389661,0.0003091348,0.0001714664,0.0001758418,0.0000199277,0.00008143747,2.223819e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005962919,"about_ca_system_score_gemma":0.00006081361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002444702,"about_ca_topic_score_gemma":0.0007208497,"domain_scores_codex":[0.9989145,0.00006412135,0.000452767,0.00023664,0.0001853957,0.0001465243],"domain_scores_gemma":[0.9993856,0.0001335678,0.0001778279,0.0001594658,0.0001148472,0.00002871553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005583997,0.000548739,0.8545843,0.00007059392,0.00008834346,0.000002662558,0.00056383,0.000003736164,0.0005257968,0.0008651115,0.00000152294,0.1371614],"study_design_scores_gemma":[0.0204724,0.002042935,0.9742171,0.0003680391,0.000009964459,3.382037e-7,0.0003512316,0.000002606738,0.001693643,0.0005880596,0.0001639575,0.00008979282],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762434,0.02243809,0.00002018881,0.00006144158,0.0000824403,0.0006258459,0.00003359152,0.000009153358,0.0004858956],"genre_scores_gemma":[0.9930179,0.006636058,0.0001850318,0.00006556421,0.00001238758,0.00003410853,0.00001983295,0.000008543658,0.00002061095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1370716,"threshold_uncertainty_score":0.4493867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007269823551129115,"score_gpt":0.2827602829955768,"score_spread":0.2754904594444477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}